Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
Popejoy MW, Paterson DL, Cloutier D, Huntington JA, Miller B, Bliss CA, Steenbergen JN, Hershberger E, Umeh O, Kaye KS. Popejoy MW, et al. Among authors: paterson dl. J Antimicrob Chemother. 2017 Jan;72(1):268-272. doi: 10.1093/jac/dkw374. Epub 2016 Oct 5. J Antimicrob Chemother. 2017. PMID: 27707990 Clinical Trial.
Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.
Paterson DL, Muto CA, Ndirangu M, Linden PK, Potoski BA, Capitano B, Bonomo RA, Aron DC, Donskey CJ. Paterson DL, et al. Antimicrob Agents Chemother. 2008 Feb;52(2):465-9. doi: 10.1128/AAC.01316-06. Epub 2007 Nov 19. Antimicrob Agents Chemother. 2008. PMID: 18025111 Free PMC article.
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL. Hawser SP, et al. Among authors: paterson dl. Antimicrob Agents Chemother. 2009 Aug;53(8):3280-4. doi: 10.1128/AAC.00426-09. Epub 2009 Jun 8. Antimicrob Agents Chemother. 2009. PMID: 19506060 Free PMC article.
Escherichia coli ST131 producing CTX-M-15 in Australia.
Sidjabat HE, Derrington P, Nimmo GR, Paterson DL. Sidjabat HE, et al. Among authors: paterson dl. J Antimicrob Chemother. 2010 Jun;65(6):1301-3. doi: 10.1093/jac/dkq098. Epub 2010 Apr 8. J Antimicrob Chemother. 2010. PMID: 20378669 No abstract available.
Pharmacokinetic evaluation of piperacillin-tazobactam.
Hayashi Y, Roberts JA, Paterson DL, Lipman J. Hayashi Y, et al. Among authors: paterson dl. Expert Opin Drug Metab Toxicol. 2010 Aug;6(8):1017-31. doi: 10.1517/17425255.2010.506187. Expert Opin Drug Metab Toxicol. 2010. PMID: 20636224 Review.
Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.
Waltner-Toews RI, Paterson DL, Qureshi ZA, Sidjabat HE, Adams-Haduch JM, Shutt KA, Jones M, Tian GB, Pasculle AW, Doi Y. Waltner-Toews RI, et al. Among authors: paterson dl. Antimicrob Agents Chemother. 2011 Feb;55(2):495-501. doi: 10.1128/AAC.00797-10. Epub 2010 Dec 6. Antimicrob Agents Chemother. 2011. PMID: 21135189 Free PMC article.
643 results